{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 20,
        "end": 36
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 69,
        "end": 74
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 114,
        "end": 122
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 136,
        "end": 144
      }
    },
    {
      "id": "T8",
      "obj": "Chemical",
      "span": {
        "begin": 217,
        "end": 225
      }
    },
    {
      "id": "T9",
      "obj": "Chemical",
      "span": {
        "begin": 257,
        "end": 274
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 92,
        "end": 108
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 61,
        "end": 66
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 92,
        "end": 98
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "10945855_3",
  "text": "We demonstrate that p-fluorofentanyl more potently activates GIRK1 / GIRK2 channels through opioid receptors than fentanyl and that the p-fluoro substitution also changes the potency profile from mu > kappa > delta ( fentanyl ) to mu > delta > or = kappa ( p- fluorofentanyl ) ."
}
